February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients ...
February 18, 2008 – OrbusNeich’s Genous Bio-engineered R stent is feasible and safe for use in acute myocardial ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
February 13, 2008 - Nfocus Neuromedical Inc. announced that the company has received CE mark approval for the CardioVasc ...
February 12, 2008 - Boston Scientific Corp. reported that a U.S. District Court jury in Marshall, TX, has reached a ...
February 12, 2008 – The FDA, National Heart Lung & Blood Institute (NHLBI) and National Science Foundation, are ...
February 11, 2008 - The first patient has enrolled in the PROENCY (PROMUS, Endeavor and Cypher) European registry ...
February 11, 2008 - Boston Scientific Corp. today announced that the first patient has been enrolled in its PROENCY ...
February 7, 2008 - A Northwestern University Feinberg School of Medicine researcher has launched the first U.S ...
February 7, 2008 - Tryton Medical Inc.’s Side Branch Stent obtains CE Mark approval based on results in the Tryton ...
February 5, 2008 – CV Therapeutics Inc. and Medlogics Device Corp. entered into an agreement under which Medlogics has ...
February 5, 2008 - The FAMILION test for Long QT Syndrome (LQTS) has met the Blue Cross and Blue Shield Association ...
January 31, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ...
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient ...
February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...